BIOMAT Database Logo BIOMAT Database Logo

Phase II study of esorubicin in patients with advanced colorectal carcinoma and no prior chemotherapy: an Illinois Cancer Council Trial. 1987

G Y Locker, and T Hoeltgen, and L Kilton, and S Krauss, and M McNamara, and R Blough, and C Johnson

UI MeSH Term Description Entries
D007087 Illinois State bounded on the north by Wisconsin, on the east by Lake Michigan, Indiana, and Kentucky, on the west by Missouri and Iowa, and on the south by Kentucky.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D012004 Rectal Neoplasms Tumors or cancer of the RECTUM. Cancer of Rectum,Rectal Cancer,Rectal Tumors,Cancer of the Rectum,Neoplasms, Rectal,Rectum Cancer,Rectum Neoplasms,Cancer, Rectal,Cancer, Rectum,Neoplasm, Rectal,Neoplasm, Rectum,Rectal Cancers,Rectal Neoplasm,Rectal Tumor,Rectum Cancers,Rectum Neoplasm,Tumor, Rectal
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation

Related Publications

G Y Locker, and T Hoeltgen, and L Kilton, and S Krauss, and M McNamara, and R Blough, and C Johnson
Phase II trial of esorubicin in patients with advanced colorectal carcinoma.
October 1986, Cancer treatment reports,
G Y Locker, and T Hoeltgen, and L Kilton, and S Krauss, and M McNamara, and R Blough, and C Johnson
Phase II trial of teniposide in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial.
February 1986, Cancer treatment reports,
G Y Locker, and T Hoeltgen, and L Kilton, and S Krauss, and M McNamara, and R Blough, and C Johnson
Phase II trial of mitolactol in previously treated and untreated patients with advanced colorectal cancer: an Illinois Cancer Council trial.
October 1984, Cancer treatment reports,
G Y Locker, and T Hoeltgen, and L Kilton, and S Krauss, and M McNamara, and R Blough, and C Johnson
Phase II trial of fludarabine phosphate in advanced renal cell carcinoma: an Illinois Cancer Council Study.
July 1989, Investigational new drugs,
G Y Locker, and T Hoeltgen, and L Kilton, and S Krauss, and M McNamara, and R Blough, and C Johnson
Teniposide in advanced breast cancer. A phase II trial in patients with no prior chemotherapy.
May 1992, Annals of oncology : official journal of the European Society for Medical Oncology,
G Y Locker, and T Hoeltgen, and L Kilton, and S Krauss, and M McNamara, and R Blough, and C Johnson
Phase II trial of echinomycin in advanced hormone-resistant prostate cancer. An Illinois Cancer Council study.
January 1994, Investigational new drugs,
G Y Locker, and T Hoeltgen, and L Kilton, and S Krauss, and M McNamara, and R Blough, and C Johnson
Phase II trial of esorubicin in patients with advanced melanoma.
March 1987, Cancer treatment reports,
G Y Locker, and T Hoeltgen, and L Kilton, and S Krauss, and M McNamara, and R Blough, and C Johnson
Phase II trial of spirogermanium in advanced non-small cell lung cancer. An Illinois Cancer Council Study.
July 1989, Investigational new drugs,
G Y Locker, and T Hoeltgen, and L Kilton, and S Krauss, and M McNamara, and R Blough, and C Johnson
Bisantrene in advanced, hormone-resistant carcinoma of the prostate: an Illinois Cancer Council phase II study.
August 1990, Investigational new drugs,
G Y Locker, and T Hoeltgen, and L Kilton, and S Krauss, and M McNamara, and R Blough, and C Johnson
Phase II trial of caracemide (NSC 253272) in advanced unresectable non-small cell bronchogenic carcinoma. An Illinois Cancer Council study.
April 1992, Investigational new drugs,
Copied contents to your clipboard!